Immune response modulation via anti-inflammatory cytokines (Not applicable - this is a mechanism, not a single molecule)

Anti-inflammatory cytokines are a series of immunoregulatory molecules that control the pro-inflammatory cytokine response and work to resolve inflammation and restore tissue homeostasis[1]. These signaling proteins include IL-10, IL-4, IL-1RA, TGF-β, IL-11, and IL-13, among others[2]. They function by suppressing the production of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1, promoting regulatory T-cell development, and facilitating tissue repair[1][2]. IL-10 is particularly potent, capable of counter-regulating production and function of pro-inflammatory cytokines at multiple levels[2]. These cytokines bind to specific receptors on immune cells, triggering signaling cascades that modulate gene expression and cellular responses. Maintaining a balance between pro-inflammatory and anti-inflammatory cytokines is crucial for proper immune function and prevention of chronic inflammatory diseases[1]. Acute administration of anti-inflammatory cytokines like IL-10 has shown therapeutic potential in suppressing pain facilitation in various animal models[2]. The therapeutic manipulation of this pathway represents a possible treatment approach for pathological pain, autoimmune conditions, and chronic inflammatory disorders[4].

Other names

Anti-inflammatory cytokine pathwayimmunoregulatory cytokinesanti-inflammatory immune response

Suppression of pro-inflammatory cytokine expression (TNF-α, IL-6, IL-1); Up-regulation of endogenous anti-cytokines; Down-regulation of pro-inflammatory cytokine receptors; Inhibition of macrophage activation; Competitive receptor binding (e.g., IL-1RA blocking IL-1β receptor); Suppression of inflammatory pathways; Regulation of T cell activation and proliferation.